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ABSTRACT 
PURPOSE: Studies that have attributed gains in lean body mass to dietary supplementation 
during RE training have not reported these changes alongside adaptations at the cellular and sub-
cellular levels. Therefore, the purpose of this study was to examine the effects of two popular 
supplements; whey protein (WP) and creatine monohydrate (CrM) (both separately and in 
combination) on body composition, muscle strength, fiber-specific hypertrophy (i.e., type-I, IIa, 
IIx) and contractile protein accrual during RE training. METHODS: In a double-blind, 
randomized protocol, resistance-trained males were matched for strength and placed into one of 
four groups: creatine/carbohydrate (CrCHO), creatine/whey protein (CrWP), WP-only or 
carbohydrate–only (CHO) (1.5g/kg body wt/day). All assessments were completed the week 
before and after an 11 week structured, supervised RE program. Assessments included strength 
(1RM, three exercises), body composition (DEXA) and vastus lateralis muscle biopsies for 
determination of muscle fiber type (I, IIa, IIx), cross-sectional area (CSA), contractile protein 
and creatine (Cr) content. RESULTS: Supplementation with CrCHO, WP and CrWP resulted in 
significantly greater (P < 0.05) 1RM strength improvements (three of three assessments) and 
muscle hypertrophy compared to CHO. Up to 76% of the strength improvements in the squat 
could be attributed to hypertrophy of muscle involved in this exercise. However, the hypertrophy 
responses within these groups varied at the three levels assessed (i.e., changes in lean mass, 
fiber-specific hypertrophy and contractile protein content). CONCLUSIONS: Although WP 
and/or CrM appear to promote greater strength gains and muscle morphology during RE training, 
the hypertrophy responses within the groups varied. These differences in skeletal muscle 
morphology may have important implications for various populations and therefore, warrant 
further investigation. 
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INTRODUCTION 
Paragraph 1: Whey protein (WP) and creatine monohydrate (CrM) are two dietary supplements 
commonly used to promote muscle strength and hypertrophy during resistance exercise (RE) (5; 
24). WP supplements generally contain a higher concentration of essential amino acids (EAA) 
than other protein sources (5), and have rapid absorption kinetics (9). Supplementation results in 
a high blood amino acid peak and stimulation of protein synthesis similar to a dose of EAA (21).  
WP-containing meals provide a higher postprandial leucine balance and net protein gain in 
young and older men compared to isonitrogenous casein meals (9).  Although some studies have 
shown greater strength and/or lean body mass (LBM) gains with WP compared to matched 
groups given carbohydrate (CHO) (6) or casein (8) during RE training, no studies have assessed 
skeletal muscle adaptations in response to RE training and WP supplementation. The chronic use 
of CrM to increase muscle strength and LBM is also a common strategy among various adult 
populations that exercise (24). The beneficial effects of oral CrM supplementation are thought to 
be dependant on the extent of Cr accumulation within muscle (14). However, this response can 
be highly variable between subjects (17). For this reason, dietary strategies, such as combining 
CrM with carbohydrate (CHO) (16) or protein (27) have been used to enhance Cr uptake.  
Paragraph 2: Studies that have attributed gains in LBM to dietary supplementation during RE 
training have not reported these changes alongside adaptations at the cellular level (i.e., fiber-
specific, type-I, IIa, IIx hypertrophy) (4; 6; 8; 16; 25). Those that have reported fiber-specific 
hypertrophy (1; 10; 28) have not confirmed this response with changes at the sub-cellular level 
(i.e., contractile protein content). For example, the combination of CrM with CHO has been 
shown to provide greater improvements in strength and body composition (i.e. increase LBM 
with no increase in fat mass) compared to CHO alone (16). CrM combined with WP has also 
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been shown to augment muscle strength and LBM when compared to CHO or WP-only 
supplementation (6). However, no studies have examined the effects of CrM and WP 
supplementation on strength and body composition changes alongside muscle characteristics such 
as fiber-specific (i.e., type-I, IIa, IIx) hypertrophy and contractile protein content. Therefore, the 
aim of this study was to examine the effects of combining CrM with CHO and with WP during 
RE training in comparison to WP and CHO alone, on strength, body composition and fiber-
specific (i.e., type-I, IIa, IIx) hypertrophy as well as muscle Cr and contractile protein content . 
The first hypothesis was that supplementation with CrM and WP or CrM and CHO would 
provide greater benefits than WP or CHO alone. Due to the benefits reported previously with WP 
(6; 8), a secondary hypothesis was that the combination of CrM and WP would provide greater 
benefits than the combination of CrM and CHO.  
 
METHODS 
Participants 
Paragraph 3: Thirty-three recreational male bodybuilders met the requirements to commence 
this study that involved pre-post assessments and supplementation during 11 weeks of RE 
training. To qualify as participants the men (a) had no current or past history of anabolic steroid 
use, (b) had been training consistently (i.e., 3-5 days per week) for the previous six months, (c) 
submitted a detailed description of their current training program, (d) had not ingested any 
ergogenic supplement for 12-weeks prior to the start of supplementation, and (e) agreed not to 
ingest any other nutritional supplements, or non-prescription drugs that may affect muscle 
growth or the ability to train intensely during the study. All participants were informed of the 
potential risks of the investigation before signing an informed consent document approved by the 
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Human Research Ethics Committee of Victoria University of Technology and the Department of 
Human Services, Victoria, Australia. All procedures conformed to National Health and Medical 
Research Council guidelines for the involvement of human subjects for research and conformed 
to the policy statement regarding the use of human subjects and written informed consent 
published by Medicine & Science in Sports & Exercise®. 
Paragraph 4: After baseline assessments, the men were matched for maximal strength (1RM) in 
three weight lifting exercises (see strength assessments) and then randomly assigned to one of 
four supplement groups in a double-blind fashion; whey protein (WP), CrM and whey protein 
(CrWP), CrM and carbohydrate (CrCHO), or carbohydrate–only (CHO).  
Supplementation  
Paragraph 5: Participants were instructed to consume 1.5 grams of the supplement per kilogram 
of body weight per day (1.5g-1kg-1day) while maintaining their habitual daily diet.  The chosen 
supplement dose was based on previously reported intakes of this population (18). The 
supplements were tested to comply with label claims before leaving the place of manufacture 
(AST Sports Science, Golden, CO, USA). Additionally, the WP supplement was independently 
assessed by Naturalac Nutrition LTD (Level 2/18 Normanby Rd Mt Eden, New Zealand) on two 
separate occasions, and matched labelled ingredients on both occasions. The supplements were 
provided in identical containers with sealed, tamper-proof lids, and they were similar in energy 
content on a g-1kg basis. For example, an 80kg participant in the WP group consumed 120g/day 
of a supplement that contained approximately 103g protein, <6g carbohydrate, <1.2g fat and 
1864 kJ (447 Kcal), whereas an 80kg participant in the CHO group consumed the same dose of a 
supplement that contained 106g carbohydrate, 0 protein or fat and 1770 kJ (424 Kcal). The Cr-
containing supplements (CrCHO and CrWP) contained a 1 week loading phase with CrM (0.3g-
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1kg-1day) that was followed by a maintenance phase (0.1g-1kg-1day) for the duration of the study 
(weeks 2-11) — a protocol has been shown previously to augment muscle strength and 
hypertrophy during RE training (28). For example, an 80kg participant in the CrCHO group 
consumed 120g-1day of a loading phase supplement that contained 85g carbohydrate, 24g CrM/ 
and 1420 kJ (340 Kcal), and then a maintenance phase supplement (weeks 2-11), that provided 
98.9g carbohydrate, 8.4g CrM and 1651 kJ (396 Kcal). A participant of the same weight in the 
CrWP group consumed a loading phase supplement (week 1) that contained 83g protein, <4.8g 
carbohydrate, <1g fat, 24g CrM and 1500 kJ (359 Kcal) followed by a maintenance phase 
supplement (weeks 2-11), that contained 96g protein, <5.5g carbohydrate, <1g fat, 8.4g CrM and 
1729 kJ (415 Kcal). 
Paragraph 6: The participants were asked to consume their supplement dose in three equal 
servings throughout the day (described with measuring scoops provided). For example, the 
participants were asked to consume one serving mid-morning, one serving as soon as they 
finished each workout in the afternoon (or similar time on non-training days), and one serving in 
the evening before sleep. The participants were weighed on a Seca 703 stainless steel digital 
medical scale (Seca, Perth, WA) every week to track body mass. Where a substantial change in 
body mass (approximately 2 kgs) from baseline was observed, the participant was shown how to 
adjust the supplement dose to correspond with the increase in body weight. Participants were 
given approximately a one-week supply of the supplement at the start of each week and asked to 
return the container before they received the next weeks supply as an act of compliance to the 
dosing procedure. In addition to having to return the container, the participants were asked to 
document the time of day they took the supplement in nutrition diaries that were provided. The 
participants’ diets were monitored and assessed as previously described (7). In brief, each 
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participant was asked to submit three written dietary recordings; one before and two during the 
study (each recording consisted of 3-days) for the calculation macronutrient and energy intake. 
Energy intake is expressed in kcal-1kg of body weight per day; protein and carbohydrate are 
expressed in g-1kg of body weight per day. The participants were asked to report any adverse 
events from the supplements in the nutrition diaries provided. No adverse events were reported 
by the participants.    
Resistance Training Protocol  
Paragraph 7: Questionnaires demonstrated that the participants had been training consistently 
(i.e., 3-5 days per week) for at least six months before expressing interest in this investigation. 
However, to ensure the participants were trained and to minimize the impact of a new program 
on strength and hypertrophy adaptations, the men underwent a structured training program 
(similar to the one used in this study) for 8 to 12 weeks prior to commencing this trial. The 11 
week RE program used in the study (Max-OT™, AST Sport Science, Golden, CO, USA) has 
been described elsewhere (7; 8) and began the week immediately after baseline assessments.  In 
brief, the program was designed specifically to increase strength and muscle size. It consisted of 
high-intensity (overload) workouts using mostly compound exercises with free weights. Training 
intensity for the program was determined using repetition maximums (RM). Qualified personnel 
supervised each participant on a one-to-one basis, every workout. Aside from the personal 
training each participant received during the 10 week program, they also kept training diaries to 
record exercises, sets, repetitions performed and the weight utilized throughout the program and 
these were viewed by the trainer on a weekly basis. The following assessments occurred in the 
week before and after the RE program.   
Strength testing  
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Paragraph 8: Strength assessments consisted of the maximal weight that could be lifted once 
(1RM) in three weight training exercises: barbell bench press, squat and cable pulldown. A 
recognized 1RM testing protocol and exercise execution guidelines were followed as has been 
previously documented (2). Briefly, the participant’s maximal lift was determined within no 
more than five single repetition attempts following three progressively heavier warm up sets. 
Participants were required to successfully lift each weight before attempting a heavier weight. 
Each exercise was completed before the next attempt and in the same order. Reproducibility for 
these tests was determined on 2 separate occasions; Intra class correlations (ICC) and standard 
error of measurement (SEM) for 1RM tests were bench press r = 0.998, SEM 1.0kg; squat r =  
0.995, SEM 2.5kg;  pulldown r = 0.982, SEM 2.5kg.     
Body Composition  
Paragraph 9: Lean body mass (total fat free mass), fat mass and body fat percentage were 
determined using a Hologic QDR-4500 dual energy x-ray absorptiometry (DEXA) with the 
Hologic version V 7, REV F software (Waltham, MA). Whole body scans were performed on the 
same apparatus, by the same licensed operator. Quality control calibration and scanning 
procedures were performed as previously described (8). Participants were scanned at the same 
time of the day, that is, in the morning in a fasted state. For longitudinal studies in which 
relatively small changes in body composition are to be detected, whole body scanning with this 
instrument has been shown to be accurate and reliable (CV 0.8-2.8%) (23) 
 Muscle analyses 
Paragraph 10: Muscle biopsies for determination of muscle fiber type, cross-sectional area 
(CSA), contractile protein content and Cr concentrations were taken in the week before and after 
the RE program. Biopsies (100-450mg) were taken using the percutaneous needle technique with 
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suction to ensure adequate sample size (12) at a similar depth in the vastus lateralis muscle by 
the same medical practitioner. A small part of the sample was immediately frozen for assessment 
of contractile protein content and Cr. The remaining tissue was mounted using OCT medium and 
snap frozen in isopentane pre-cooled in liquid nitrogen and stored at -80o C for histochemical 
analysis to classify muscle fiber types-I, IIa and IIx based on the stability of their ATPase 
activity, as previously described (7).  Fiber type percentages and CSA were determined from 
sections containing a mean of 210 (range 130-400) fibers. Samples were measured on two 
separate occasions for day to day reproducibility ICC and SEM for fiber type distribution were 
type I r = 0.822, SEM 1.8%;  type IIa r = 0.941, SEM 1.3%;  type IIx r = 0.945, SEM 1.2%. For 
mean area of fiber type I r = 0.972, SEM 87µm2; type IIa r = 0.984, SEM 100µm2; type IIx r = 
0.967, SEM 141µm2. Approximately 5 mg of muscle was used to determine contractile protein 
content as detailed by Beitzel et al. (3) and reported previously (7). Two mg of muscle was used 
to analyze Cr concentrations using fluorimetric techniques as in Hultman et al., (14), data is 
expressed as mmol-1kg dry weight. Samples were run twice on two separate occasions, ICC and 
SEM for contractile protein content were r = 0.984, SEM 2.1mg/g; Cr  r = 0.881, SEM 22. 
Statistics 
Paragraph 11: Statistical evaluation of the data was accomplished by two-way repeated 
measures analysis of variance (ANOVA) with group (supplement) and time (training) as the 
factors using SPSS statistical analysis software (SPSS v 11.0; Chicago, Illinois). Where 
significant main effects were identified by ANOVA, tukeys post hoc analysis was performed to 
locate differences. A priori power testing was based on previous data on changes in strength, 
body composition and contractile protein data obtained by our laboratory (7; 8) and others (30). 
The testing indicated group sizes of between 4 and 7 participants were required to show 
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significance at an alpha level of 0.05 and a power of 0.8. Test-retest reliability was quantified 
using the intraclass correlation coefficient (ICC) two-way ANOVA (mixed effects model) and 
the SEM (29). Simple regression was used to determine significant relationships among the 
deltas for selected variables. A p value of less than 0.05 was designated to indicate statistical 
significance. A p value of less than 0.09 was considered a trend. 
 
RESULTS 
Starting characteristics 
Paragraph 12: Four participants did not attend the required amount of supervised training 
sessions (75%) or provide all dietary records. Therefore, their data was not included. 
Additionally, three participants chose not to return for final biopsies. This reduced the number of 
the groups to 7 = CHO, 5 = WP, 8 = CrCHO and 6 = CrWP. Starting characteristics of these 
participants are shown in table 1. There were no differences between the groups in any variables 
at the start of the study (P > 0.05).  
Dietary Analyses 
Paragraph 13: Table 2 shows the average of three day written dietary recalls for energy (Kcal-
1kg-1d) carbohydrate and protein (g-1kg-1d) of the groups before, in the first and last week of the 
training program. Data does not include supplementation. No differences were identified 
between the groups or across time with regard to energy, or macronutrient intake (P > 0.05).        
Body composition  
Paragraph 14: All groups demonstrated a gain in body mass (time, P = 0.001) (table 3), but no 
group or group x time interaction was detected for body mass. No interactions for fat mass or 
body fat percentage were detected between the groups or across time. However, a group x time 
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interaction (P = 0.043) was observed for LBM (table 3). While each of the groups demonstrated 
an increase (time, P = 0.001) in LBM after the program (CrCHO +3.7kg), (CrWP +3.4), (WP 
+2.3kg), (CHO +0.7), only the CrCHO group’s increase in LBM was significantly greater than 
the CHO group (post hoc P < 0.05).    
Strength  
Paragraph 15: 1RM strength data (kgs) barbell bench press, cable pulldown and barbell squat 
are presented in figures 1a, b and c respectively. All groups demonstrated an improvement in 
strength in each exercise after the program (time: P = 0.0001), and a group x time interaction (P 
= 0.0001) was observed for each exercise. The CrCHO, CrWP and WP groups demonstrated a 
greater increase in strength in each exercise compared to the CHO group (post hoc P < 0.05). 
However, no differences were detected between the CrCHO, CrWP and WP groups. 
Muscle characteristics   
Paragraph 16: No changes in fiber type proportions between the groups or across time were 
detected (table 4). All groups demonstrated an increase in CSA (P < 0.05) of the type-IIa and IIx 
fibers after the program. Additionally, a group x time interaction in CSA was detected for the 
type-1 (P = 0.001; figure 2a), IIa (P = 0.001; figure 2b) and IIx (P = 0.001; figure 2c) fibers. The 
CrCHO and CrWP groups demonstrated a greater increase in CSA in each fiber type compared 
to the CHO group (post hoc P < 0.05). The CrCHO and CrWP groups also demonstrated a 
greater increase in CSA in the type-I fibers when compared to the WP group (post hoc P < 0.05). 
A trend for a greater hypertrophy of the type IIa and IIx fibers (P = 0.077 and P = 0.078, 
respectively) was also observed in the WP group compared to the CHO group.  
Paragraph 17: A group x time interaction (P = 0.001) for contractile (myofibrillar) protein 
content was also detected. The CrCHO, CrWP and WP groups each showed a greater increase in 
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contractile protein compared to the CHO group after the program (post hoc P <0.05) (figure 2d). 
Additionally, the CrCHO and CrWP groups demonstrated a trend (P = 0.07 and P = 0.08, 
respectively) for a greater increase in myofibrillar protein content compared to the WP group.  
 Paragraph 18: A group difference (P = 0.03) was detected for the Cr-treated groups in muscle 
Cr (table 5). Both the CrCHO and CrWP groups showed a higher (P < 0.05) concentration 
(mmol-1kg dry weight) of Cr compared to the WP and CHO group after the training program, but 
there was no difference between the CrCHO and CrWP groups.  
Correlations 
Paragraph 19: For all participants combined, positive correlations (P < 0.01) were detected 
between changes in muscle fiber CSA (in all fiber types) and strength gained in the 1RM squat 
exercise (figure 3). A positive correlation (P < 0.05) was also detected between the change in 
contractile protein (mg/g) and (1RM) strength improvements in the squat (figure 4). 
Additionally, positive correlations (P < 0.01) were detected between the increase in contractile 
protein and increase in muscle fiber CSA, in all fiber types (figure 5). 
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DISCUSSION 
Paragraph 20: The most important finding of this investigation was that although there were no 
differences between the groups at the start of this study and each group consumed a protein-rich 
diet, supplementation with CrCHO, WP and CrWP resulted in greater hypertrophy response (in at 
least one of three assessments) and 1RM strength gains (in three of three assessments) compared 
to CHO. Additionally, the changes in 1RM squat strength correlated strongly (r ≥ 0.7; P < 0.01) 
with the changes in muscle morphology across all groups. However, when compared to CHO, the 
hypertrophy response from supplementation with CrCHO, WP and CrWP varied at the three 
levels of muscle physiology that were assessed (i.e., LBM, fiber-specific hypertrophy and 
contractile protein content). These findings are novel as we are aware of no other RE training 
studies that have reported changes in body composition from dietary intervention alongside 
adaptations at the cellular level (i.e., fiber -specific hypertrophy) (4; 6; 8; 16; 25) and the sub-
cellular level (i.e., contractile protein content) (1; 10; 28).   
Paragraph 21: Our findings only partly support the first hypothesis proposed. That is, treatment 
with CrCHO or CrWP provided greater improvements in strength and muscle hypertrophy when 
compared to CHO but not WP. Additionally, the results do not support the second hypothesis 
proposed. That is, no greater benefit was observed from combining CrM and WP when compared 
to the combination of CrM and CHO. It is possible that small number (n) in some of the groups 
that completed this trial may have reduced the capacity to adequately detect some differences 
between the groups, particularly in major variables of interest such as changes in LBM. For 
example, although the WP, CrCHO and CrWP groups each demonstrated relatively large changes 
in LBM  (3.7%, 5.5% and 5%, respectively), compared to the CHO (1.1%) group, the only 
change in LBM deemed significantly greater than the CHO group was the CrCHO group. We 
 
 14
commenced this study with thirty four participants that provided similar group n’s to our previous 
work (7; 8) and others (28; 30) that have involved supplementation and RE training. These 
investigations reported significant differences between groups in LBM, strength and/or muscle 
hypertrophy with n’s of 9-6 in each group. For example, in a previous study completed by this 
laboratory (8) that utilized RE-trained participants and a similar protocol, supplementation with 
WP (n = 6) (1.5gm-1 kg -1 day for 10 weeks) produced significantly greater gains in LBM and 
strength compared to a group given an equivalent dose of casein (n =7). In another investigation 
that also involved RE trained participants undertaking a 10 week RE program, we were able to 
detect significant different gains in LBM between two groups (n = 8, n = 9) that consumed the 
exact same supplement at different times of the day (7). Volek et al. (28) also utilized RE-trained 
participants, a similar RE program and CrM supplementation protocol to the present study, and 
reported comparable results. That is, after the 12 week training period, CrM supplementation (n = 
9) resulted in a significantly greater gain in LBM, 1RM squat strength and muscle fiber 
hypertrophy in all fiber types assessed compared to a matched placebo-treated group (n = 10) 
(28).  Willoughby & Rosene (30) reported that supplementation with CrM (n = 8) during 12 
weeks of RE resulted in a greater increase in LBM (assessed by skin fold caliper), thigh volume, 
(relative) muscle strength, and myofibrillar protein content than a placebo-treated group (n=8) 
and a control group (n = 6). Based on prior investigations (7; 8; 28; 30) it was reasonable to 
assume that commencing the present study with thirty-four participants would be adequate. 
However, a lower than anticipated finishing n in some of the groups probably reduced the 
capacity to detect differences between the groups in LBM. We acknowledge that the small 
sample size of the groups is as an important limitation of this study. Nevertheless, unlike other 
investigations that have reported changes in body composition from dietary intervention, the 
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changes in LBM in this study are supported by a number of significant differences between the 
groups in skeletal muscle morphology that were detected at the cellular and sub-cellular levels. 
 Paragraph 22: Few have used matched placebo-treated groups and quantified the extent of 
specific muscle fiber type (i.e., type-I, IIa, IIx) hypertrophy in response to RE training and 
supplementation. Volek et al. (28) reported that treatment with CrM resulted in significantly 
greater muscle fiber hypertrophy in all fiber types assessed compared to a matched placebo-
treated group. Andersen et al. (1) reported significantly greater hypertrophy of both the type-I and 
II fibers as well as squat jump height in a group that received a pre- and post-workout protein 
supplement (25g each serving) compared to an equivalent dose of CHO during 14 weeks of RE. 
In the present study, significant differences between the groups in muscle fiber hypertrophy 
across all fiber types were detected. For example, both the CrCHO and CrWP groups 
demonstrated a greater increase in CSA in the type-I, IIa and IIx fibers (figures 2a, b and c) 
compared to the CHO group as well as a greater increase in CSA in the type-I compared to the 
WP group (figure 2a). However, no differences were detected between the WP, CrWP and 
CrCHO groups. Unlike previous studies (1; 10; 28) that have reported muscle fiber CSA changes 
in response to training and supplementation this study was able to confirm these hypertrophy 
responses with changes in contractile protein content.  
Paragraph 23: The CrCHO, CrWP, WP groups in this study each demonstrated a significantly 
greater increase in contractile protein content (mg/g of muscle) compared to the CHO group after 
the training program (figure 2d). This reflects the changes in CSA that were detected, particularly 
in the CrCHO and CrWP groups, and to a lesser extent, the WP group; a trend (P < 0.09) for 
greater hypertrophy of the type-IIa and IIx fibers was observed for the WP group when compared 
to the CHO group. Although no significant differences were detected between the WP, CrCHO 
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and CrWP groups in LBM gains or muscle fiber hypertrophy, a trend (P < 0.09) for a greater 
increase in myofibrillar protein content was also detected in the CrCHO and CrWP groups 
compared to the WP group. RE-induced muscle fiber hypertrophy is thought to be primarily 
responsible for improvements in force production and strength that are observed in RE-trained 
participants (26). An increase in contractile protein is thought to be an important stimulus that 
results in an increase in muscle fiber CSA (22). When all participants were combined, a strong 
relationship between changes in muscle fiber CSA (across all fiber types) and strength 
improvements in the squat exercise were evident (figure 3). A similar relationship between 
changes in contractile protein content and strength improvements in the squat was also detected 
(figure 4). Additionally, a strong relationship between changes in contractile protein content and 
muscle fiber hypertrophy (for all types) was observed (figure 5). The r values obtained suggest 
that a substantial portion (50-76%) of the strength improvements observed across all groups could 
be attributed to the changes in skeletal muscle morphology. These correlations reflect a direct 
relationship between muscle an adaptation (hypertrophy) and an improvement in functional 
strength. The barbell squat exercise was the focus of these correlation assessments simply 
because, unlike the bench press and pulldown exercise, the vastus lateralis is recruited heavily 
during this exercise. Therefore, although differences between the groups in terms of changes in 
body composition were less evident, some statistically significant differences (and strong trends) 
were detected between the groups regarding muscle fiber hypertrophy and contractile protein 
accrual. Additionally, it was these alterations in skeletal muscle morphology that were largely 
responsible for the improvements in strength in an exercise involving a related muscle group.  
However, although these results suggest a cause-and effect-relationship between muscle 
hypertrophy and strength, no mechanistic assessments were attempted.  
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Paragraph 24: Willoughby & Rosene (30) completed one of very few studies that have linked 
an enhanced hypertrophy response from RE and supplementation (i.e., increase in strength, LBM 
and thigh volume) to alterations at the molecular level that may explain these benefits. In this 
study, supplementation with CrM (6g-1day) during 12 weeks of RE resulted in a greater increase 
in LBM, muscle strength, and myofibrillar protein content to matched placebo-treated and 
control groups. These alterations corresponded with the up regulation of the genes and myogenic 
regulatory factors associated with (myosin heavy chain) contractile protein synthesis. A review 
of 22 studies involving supplementation during RE training clearly shows that CrM enhances 
weightlifting performance and the development of strength (24), and this is probably due to 
increased Cr availability during intense muscle contraction (14). More recently, Olsen et al., (20) 
reported that CrM supplementation during 16 weeks of RE amplified the training-induced 
increase in satellite cell number and myonuclei concentration in human skeletal muscle fibers, 
thereby allowing an enhanced muscle fiber growth in response to strength training. Therefore, 
supplementation with CrM may result in superior strength and hypertrophy responses by 
inducing greater satellite cell number and myonuclei concentration alongside transcriptional 
changes in muscle gene expression which may contribute to, or be a product of, CrM’s ability to 
enhance the bioenergetics of the phosphagen system. While these findings help to form a 
tempting mechanistic explanation for the greater hypertrophy responses observed in the Cr-
treated groups in the present study, they do not explain the greater increases in strength and 
contractile protein accrual detected in the WP-supplemented group.   
Paragraph 25: Although previous studies have shown that WP supplementation (1.2 to 1.5g-1kg-
1d) results in greater LBM and strength compared to matched CHO (6) and casein-treated groups 
(8), this study is the first to report changes in skeletal muscle morphology in response to RE-
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training and WP supplementation. In this study, the WP group demonstrated greater 
improvements in 1RM strength (in all three tests) compared to the CHO-treated group (figures 1a, 
b, c). Based on the correlations observed, these strength improvements can be attributed mostly to 
skeletal muscle morphology. The protein used in this study (whey isolate) is regarded a rich 
source of EAA, particularly the branch chain amino acids (BCAA) (5). Supplementation with the 
BCAA during and after RE is shown to result in greater phosphorylation (activation) of p70S6k in 
skeletal muscle; a rate limiting kinase in the signaling network controlling protein synthesis 
through translational initiation (15). More recently, supplementation with WP during RE has been 
shown to provide a similar effect in at least one of the signaling proteins that regulate protein 
synthesis through translational initiation (13). WP meals are shown to provide a high stimulation 
of protein synthesis and greater net postprandial protein gain compared to other high quality 
protein sources (9). Therefore, the frequent consumption of WP throughout the RE program in 
this study may have resulted in a greater anabolic response (i.e., higher rate of protein synthesis 
and net protein accretion) that resulted in greater synthesis of contractile protein. Although the 
findings with WP supplementation in this study are consistent with this theory, the mechanisms 
that may underline the benefits obtained from WP during RE are yet to be fully elucidated. The 
ability of the WP group to achieve similar strength gains without the large increase in LBM as 
seen in the CrCHO and CrWP groups in this study may have important sports-specific 
implications for individuals that compete in weight-restricted events. Therefore, further studies on 
the chronic effects of WP during RE are warranted, particularly at the molecular level.  
Paragraph 26: Based on the mechanistic explanations that have been proposed, one may expect 
an additive effect from combining CrM and WP on muscle strength and hypertrophy. However, 
in this study, no greater effect was observed from this supplement combination compared to the 
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combination of CrM and CHO. One explanation for this may be the influence of the CHO 
(contained in CrCHO but not the CrWP supplement). For example, all groups consumed a high 
protein intake aside from supplementation and the results of at least one longitudinal study 
suggest that once dietary protein requirements appear to be met, it is the energy content of the 
diet that has the largest effect on hypertrophy during RE (25). In other words, when CrM is 
consumed in the presence of a high protein diet, the addition of CHO may be more beneficial 
than extra protein. However, the results also suggest that the consumption of CrM with WP 
provide similar benefits to that of CrM with CHO. This may have important implications for 
populations that desire improvements from exercise but the consumption of large amounts of 
glucose is undesirable, such as those with, or at risk of, type-II diabetes. As this is the only study 
that has compared the effects of two different CrM-containing supplements on skeletal muscle 
morphology during RE, the results obtained warrant further study.   
Paragraph 27: Aside from the statistical evaluation of diet and the assessment of muscle 
hypertrophy at three levels, another strength of this investigation was the personalized training of 
the participants (one-to-one or one-to-two instruction of all participants during every workout). 
This level of supervision is shown to ensure better control of workout intensity and greater 
strength improvements during training (19). A personal training approach to RE supervision in 
RE training studies that involve supplementation is particularly important as it ensures a better 
chance of enhanced physiological adaptations from supplementation (28). This is based on the 
premise that those treated with supplements such as CrM and WP would be capable of training at 
a higher intensity level and progressing at a faster rate. It is important to remember that the 
instructors were blinded to the supplement groups, yet the WP, CrCHO and CrWP groups 
demonstrated significantly greater hypertrophy (in at least one of three assessments) and gains in 
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1RM strength (in three of three assessments) and thus, generally supports our theory. Training 
and dietary strategies that augment the adaptations desired from RE should continue to receive 
greater attention from within the scientific community as this research has important implications 
for an ageing population but also others that have a reduced capacity for exercise such as the frail 
elderly, cardiac rehabilitation patients or those living with cachectic conditions such as HIV, 
various forms of cancer.  
Paragraph 28: In conclusion, this study examined the effects supplementation with CrCHO, 
CrWP, WP or CHO (1.5g/kg body wt/day) using four groups of matched, RE-trained males 
during 11 weeks of supervised RE training. Pre-post assessments demonstrated that 
supplementation with CrCHO, WP and CrWP resulted in significantly greater increases in 1RM 
strength (in three assessments) compared to supplementation with CHO. Up to 76% of the 
strength improvements in the squat could be attributed to hypertrophy of muscle involved in this 
exercise. However, the hypertrophy response from CrCHO, WP and CrWP varied at the three 
levels assessed (i.e., changes in lean mass, fiber-specific hypertrophy and contractile protein 
content). Therefore, although supplementation with WP and/or CrM appears to promote greater 
strength gains and muscle hypertrophy during RE training, the small number of participants 
within the groups that completed this investigation makes it difficult to draw firm conclusions 
with regard to the effects of the different supplement combinations used in this study, and thus 
warrants further investigation. 
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Captions 
 
Figure 1a Bench Press (1RM) Strength 
# Training effect, *greater increase than CHO group (P =0.0001, effect size = 0.585, power = 
0.994) (mean ± SE)  
 
Figure 1b Pulldown (1RM) Strength 
# Training effect, *greater increase than CHO group (P = 0.0001, effect size = 0.585, power = 
0.995) (mean ± SE) 
 
Figure 1c Squat (1RM) Strength  
# Training effect, *greater increase than CHO group (P = 0.0001, effect size = 0.592, power = 
0.996) (mean ± SE) 
 
Figure 2a muscle fiber CSA type-I 
# Training effect *greater increase than CHO group, †greater increase than WP group (P = 0.001, 
effect size = 0.541, power = 983) (mean ± SE) 
 
Figure 2b Muscle fiber CSA type-IIa  
# Training effect *greater increase than CHO group (P = 0.001, effect size = 0.589, power = 995) 
(mean ± SE) 
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Figure 2c Muscle fiber CSA type-IIx 
# Training effect *greater increase than CHO group (P = 0.001, effect size = 0.596, power = 
0.996) (mean ± SE) 
 
Figure 2d Contractile protein (mg/g) muscle 
# Training effect *greater increase than CHO group (P = 0.001, effect size = 0.717, power = 1.00) 
(mean ± SE) 
 
Figure 3 Relationship between muscle fiber hypertrophy and 1RM strength improvements in the 
squat.  
 
Figure 4.  Relationship between change in contractile protein content and 1RM strength gains in 
the squat.  
 
Figure 5. Relationship between contractile protein content and muscle fiber hypertrophy 
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Table 1 Baseline characteristics  
Characteristics CHO     WP CrCHO CrWP 
Age (yrs) 24 ± 7 24 ± 5 25 ± 6 25 ± 4 
Training age (yrs) 6 ± 3 5 ± 2 6 ± 3 4 ± 2 
Height (cm) 177 ± 5 181 ± 8 177 ± 6 190 ± 7 
Body mass (kg) 76 ± 12 70 ± 11 84 ± 14 84 ± 12 
Lean mass (kg) 62 ±  7 59 ± 7 67 ± 8 68 ± 6 
Fat mass (kg) 13 ± 7 11 ± 4 17 ± 7 16 ± 6 
CSA type-I (µm2) 3662 ± 273 3423 ± 88 3656 ± 593 3699 ± 774
CSA type-IIa (µm2) 4674 ± 803 4529 ± 223 4673 ± 661 4458 ± 919
CSA type-IIx (µm2) 4253 ± 656 4220 ± 223 4354 ± 972 4057 ± 604
 1RM Bench (kg)  99 ± 16 98 ± 13 104 ± 22 106 ± 26 
1RM Squat (kg) 125 ± 25 118 ± 26 118 ± 18 123 ± 37 
1RM Pulldown (kg) 90 ± 12 86 ± 11 89 ± 18 88 ± 13 
Values are means ± SD.  
 
Table 2 Dietary analyses 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Variable CHO WP CrCHO CrWP 
Energy intake (Kcal-1 kg -1d)  
before 
week 1 
week 11 
 
36.8 ± 7.2
36.5 ± 5.3
36.4 ± 5.9
 
41.6 ± 4.8
40.5 ± 3.5
39.1 ± 3.3
 
42.0 ± 6.1
37.3 ± 3.8
38.4 ± 4.1
 
40.8 ± 3.6 
39.9 ± 2.9 
39.9 ± 3 
Carbohydrate (g-1kg-1day) 
before 
week 1 
week 11 
 
2.9 ± 0.6 
2.8 ± 0.6 
2.7 ± 0.4 
 
4.0 ± 0.6 
3.7 ± 0.4 
4.0 ± 1.2 
 
4.4 ± 1.2 
3.7 ± 1.0 
3.7 ± 0.6 
 
3.8 ± 1.4 
3.9 ± 1.4 
4.7 ± 1.9 
Protein  (g-1kg-1day) 
Before 
week 1 
week 11 
Fat  (g-1kg-1day) 
Before 
week 1 
week 11 
 
1.6 ± 0.3 
1.7 ± 0.2 
1.6 ± 0.1 
 
2.1 ± 0.6 
2.1 ± 0.5 
2.1 ± 0.6 
 
1.6 ± 0.2 
1.7 ± 0.2 
1.6 ± 0.1 
 
2.2 ± 0.4 
2.1 ± 0.4 
2.0 ± 0.3 
 
1.5 ± 0.3 
1.5 ± 0.3 
1.5 ± 0.3 
 
2.0 ± 0.6 
1.9 ± 0.6 
2.0 ± 0.7 
 
2.1 ± 1.0 
1.9  ± 0.8 
1.7 ± 0.7 
 
2.1 ± 1.0 
1.9  ± 0.8 
1.7 ± 0.7 
 
values are mean ± SD 
 
Table 3 Body Mass and Composition 
Variable CHO WP CrCHO CrWP 
Body mass (kg)  
PRE 
POST#
 
75.6 ± 4.7 
77.0 ± 4.8 
 
69.7 ± 5.0 
72.3 ± 4.3
 
84.2 ± 4.9  
88.2 ± 5.0 
 
83.9 ± 4.8 
87.9 ± 5.0
Lean mass (kg)  
PRE 
POST#
 
62.3 ± 2.8 
63.0 ± 2.7 
 
59.0 ± 3.2
61.3 ± 3.0
 
67.0 ± 2.6 
 71.3 ± 3.0*
 
67.9 ± 2.6
71.3 ± 2.8
Fat mass (kg)  
PRE 
POST 
 
13.2 ± 2.8 
14.0 ± 2.9 
 
10.6 ± 1.9
11.0 ± 1.6
 
16.6 ± 2.6 
17.0 ± 2.1 
 
15.9 ± 2.5
16.6 ± 2.6
Fat % 
PRE 
POST 
 
16.9 ± 2.4 
17.6 ± 2.5 
 
14.9 ± 1.7
15.0 ± 1.3
 
19.1 ± 1.9 
18.8 ± 1.3 
 
18.5 ± 1.9
18.5 ± 1.9
 # Training effect all groups (P = 0.001); *greater increase than 
 CHO group (P = 0.043, effect size = 0.297, power = 0.642) (mean ± SE). 
Table 4 Muscle fibre type (%)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
variable CHO WP CrCHO CrWP 
%Type -1 
PRE 
POST 
 
43 ± 5.9 
41 ± 4.5 
 
49.9 ± 2.6 
44.6 ± 4.3 
 
43.9 ± 2.5 
46.7 ± 3.5
 
41.4 ± 3.5 
43.2 ± 3.2
%Type-IIa 
PRE 
POST 
 
38.3 ± 5.3 
39.0 ± 4.0 
 
30.0 ± 3.1 
35.3 ± 4.0 
 
38.3 ± 3.3 
36.7 ± 4.0
 
36.9 ± 2.8 
33.7 ± 2.5
%Type-IIx 
PRE 
POST 
 
18.7 ± 2.8 
20.2 ± 2.5 
 
18.0 ± 1.7 
17.7 ± 2.7 
 
17.8 ± 1.8 
16.5 ± 1.4
 
21.6 ± 2.4 
23.1 ± 1.4
(mean ± SE) 
Table 5 Muscle creatine 
Variable (mmol/kg dry wt) CHO WP CrCHO CrWP 
Total Cr  
PRE 
POST 
 
94.2 ± 10.1 
95.3 ± 10.5
 
107.1 ± 8.7 
100.5 ± 9.5
 
103.6 ± 8.3 
113 ± 24.1*
 
109 ± 16.6 
125.3 ± 19.6* 
*Greater than WP and CHO groups (P = 0.03, effect size = 0.340, power = 0.683) (mean ± SE) 
